A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC DPI;   Drug: Placebo DPI;   Drug: ICS/LABA medication;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2014 Category: Research Source Type: clinical trials

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition:   Pulmonary Disease, Chronic ObstructiveInterventions:   Drug: UMEC DPI;   Drug: Placebo DPI;   Drug: ICS/LABA medication;   Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor:   GlaxoSmithKlineCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2014 Category: Research Source Type: clinical trials

Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Condition:   AsthmaInterventions:   Drug: A006 DPI;   Drug: A006 DPI;   Other: Placebo DPI;   Drug: Proventil® MDI;   Drug: Proventil® MDISponsor:   Amphastar Pharmaceuticals, Inc.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 6, 2014 Category: Research Source Type: clinical trials

Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Condition:   AsthmaInterventions:   Drug: A006 DPI;   Drug: A006 DPI;   Other: Placebo DPI;   Drug: Proventil® MDI;   Drug: Proventil® MDISponsor:   Amphastar Pharmaceuticals, Inc.Recruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2014 Category: Research Source Type: clinical trials

A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
Condition:   AsthmaInterventions:   Drug: Albuterol MDPI;   Drug: PlaceboSponsors:   Teva Branded Pharmaceutical Products, R&D Inc.;   Teva Pharmaceutical IndustriesRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2014 Category: Research Source Type: clinical trials

A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
Condition:   AsthmaInterventions:   Drug: Albuterol MDPI;   Drug: PlaceboSponsors:   Teva Branded Pharmaceutical Products, R&D Inc.;   Teva Pharmaceutical IndustriesRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2014 Category: Research Source Type: clinical trials

A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
Condition:   AsthmaInterventions:   Drug: Albuterol MDPI;   Drug: PlaceboSponsor:   Teva Branded Pharmaceutical Products, R&D Inc.Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2014 Category: Research Source Type: clinical trials

A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
Condition:   AsthmaInterventions:   Drug: Albuterol MDPI;   Drug: PlaceboSponsor:   Teva Branded Pharmaceutical Products, R&D Inc.Completed - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2014 Category: Research Source Type: clinical trials

The Various Effects of Gaseous Albuterol on Serum Lactate
Condition:   AsthmaInterventions:   Drug: Normal Saline;   Drug: AlbuterolSponsor:   University Medical Center of Southern NevadaNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2014 Category: Research Source Type: clinical trials